{
    "2021-02-19": [
        [
            {
                "time": "",
                "original_text": "昭衍新药港股上市首日破发 2019年国内非临床DSA市占率第一 连续下跌",
                "features": {
                    "keywords": [
                        "昭衍新药",
                        "港股",
                        "上市首日",
                        "破发",
                        "非临床DSA",
                        "市占率第一",
                        "连续下跌"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "【权益变动】康龙化成(03759-HK)被摩根大通减持28.3828万股 减持股份",
                "features": {
                    "keywords": [
                        "康龙化成",
                        "摩根大通",
                        "减持",
                        "28.3828万股"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "JPMorgan Chase & Co.减持康龙化成股份约28.38万股 减持股份",
                "features": {
                    "keywords": [
                        "JPMorgan Chase",
                        "康龙化成",
                        "减持",
                        "28.38万股"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "68只港股获南向资金大比例持有",
                "features": {
                    "keywords": [
                        "港股",
                        "南向资金",
                        "大比例持有"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}